|
Zhilyaeva Yu.A., Mikhin V.P., Nikolaevskaya A.O., Babkin M.O.
The role of metalloproteinases in the pathogenesis of cardiovascular diseases
|
№6 / 2024
|
|
Derbeneva S.A., Pogozheva A.V., Shmeleva S.V., Sabanchieva Zh.Kh.
Unifactorial prediction of the risks of development and progression of cardiovascular diseases
|
№4 / 2024
|
|
De V.A., Batyukina S.V., Kochetkov A.I., Klepikova M.V., Konik V.A., Ostroumova O.D.
Cognitive status of patients with coronary artery disease and concomitant atrial fibrillation
|
№4 / 2024
|
|
Kochetkov A.I., Telkova S.S., Dubinina A.V., Mirzaev K.B., Shastina V.R., Cherniaeva M.S., Dashabylova V.B., Ostroumova O.D.
Pharmacotherapy of elderly multimorbid patients with atrial fibrillation in real clinical practice: practical application of STOPP/START criteria
|
№4 / 2024
|
|
Trukhan D.I., Sulimov A.F., Trukhan L.Yu.
Orofacial pain as a manifestation of myocardial ischemia
|
№1 / 2024
|
|
A.V. Dubinina, A.I. Kochetkov, A.E. Vorobyova, S.S. Eremina, K.B. Mirzaev, O.D. Ostroumova
Analysis of the structure of comorbidities and pharmacotherapy in patients with a combination of atrial fibrillation and coronary heart disease
|
№14 / 2023
|
|
O.D. Ostroumova, A.V. Dubinina, V.A. De, A.I. Kochetkov, V.B. Dashabylova, S.S. Eremina, M.V. Klepikova
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy
|
№14 / 2023
|
|
V.S. Nikiforov
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
|
№13 / 2022
|
|
B.G. Iskenderov, A.V. Zaitseva, I.N. Mozhzhukhin, M.G. Ivanchukova
Impact of coronary artery stenting on the course of chronic kidney disease in patients with stable angina
|
№13 / 2022
|
|
O.A. Polyakova (1), A.A. Chochua (1), O.V. Golovina (1), E.V. Mironova (2), O.D. Ostroumova (1)
Possibilities of using trimetazidine in the treatment of patients with ischemic heart disease and chronic heart failure
|
№13 / 2021
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), S.V. Batyukina (1), N.L. Lyakhova (3)
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
|
№3 / 2020
|
|
N.P. Lyamina (1), A.V. Kosareva (2)
The justified position of rosuvastatin in therapeutic practice
|
№9 / 2019
|
Русский
